Risk for developing myelodysplastic syndromes in prostate cancer patients definitively treated with radiation.

@article{Mukherjee2014RiskFD,
  title={Risk for developing myelodysplastic syndromes in prostate cancer patients definitively treated with radiation.},
  author={Sudipto Mukherjee and C Adinaryana Reddy and Jay P. Ciezki and M. Saied Abdel-Wahab and Ram{\'o}n V. Tiu and Edward A. Copelan and Anjali A Advani and Yogen Saunthararajah and Katarina Paulic and Sean Hobson and Jaroslaw Maciejewski and Brian James Bolwell and Matt E. Kalaycio and Robert Dreicer and Eric A Klein and Mikkael A. Sekeres},
  journal={Journal of the National Cancer Institute},
  year={2014},
  volume={106 3},
  pages={djt462}
}
BACKGROUND Exposure to ionizing radiation has been linked to myelodysplastic syndromes (MDS); it is not clear whether therapeutic radiation doses used for prostate cancer pose an increased MDS risk. METHODS We performed a retrospective cohort study of prostate cancer patients diagnosed between 1986 and 2011 at Cleveland Clinic, comparing those who underwent definitive treatment with radical prostatectomy (RP) to radiotherapy either external beam radiotherapy (EBRT) or prostate interstitial… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 66 references

The proportion of second cancers attributable to radiotherapy treatment in adults: a prospective cohort study in the US SEER cancer registries

  • AB de Gonzalez, RE Curtis, SF Kry
  • Lancet Oncol
  • 2011
Highly Influential
5 Excerpts

Cancer statistics ,

  • RA Kleinerman, JV Liebermann, FP Li
  • 2013

SEER Cancer Statistics Review, 1975-2008

  • M Howlader, AM Noone, M Krapcho
  • National Cancer Institute, Section 30.Bethesda…
  • 2011

Similar Papers

Loading similar papers…